Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sy

Showing results (211-220 of 341) with videos related to

Pageof 35
Sort By:
Vaccine|November 12, 2023
Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care systemKatia J Bruxvoort, Lina S Sy, Vennis Hong, et al.
The American Journal of Tropical Medicine and Hygiene|February 14, 2007
Antibody isotype responses to paramyosin, a vaccine candidate for schistosomiasis, and their correlations with resistance and fibrosis in patients infected with Schistosoma japonicum in Leyte, The PhilippinesTakeshi Nara, Kyoichi Iizumi, Hiroshi Ohmae, et al.
American Journal of Epidemiology|June 4, 2025
A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccineStanley Xu, Lina S Sy, Xuan Huang, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigensC E Rudd, E K Barber, K E Burgess, et al.
The Journal of Biological Chemistry|August 8, 2001
Novel differences between two human prion strains revealed by two-dimensional gel electrophoresisT Pan, M Colucci, B S Wong, et al.
Brain Research|March 30, 2001
Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodiesT Liu, T Zwingman, R Li, et al.
Vaccine|April 11, 2025
Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccinesKatia J Bruxvoort, Lina S Sy, Richard Contreras, et al.
Journal of Clinical and Translational Science|August 11, 2022
Evidence-based practice strategies for faculty professional development in clinical translational research at Institutional Development Award (IDeA) state institutions in the Mountain WestMerle R Kataoka-Yahiro, Larissa Myaskovsky, Ruben K Dagda, et al.
Cellular Immunology|February 13, 2001
The expression and potential function of cellular prion protein in human lymphocytesR Li, D Liu, G Zanusso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2015
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal DiseaseHung Fu Tseng, Yi Luo, Jiaxiao Shi, et al.
Pageof 35

Showing results (211-220 of 341) with videos related to

Sort By:
Pageof 35
Vaccine|November 12, 2023
Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care systemKatia J Bruxvoort, Lina S Sy, Vennis Hong, et al.
The American Journal of Tropical Medicine and Hygiene|February 14, 2007
Antibody isotype responses to paramyosin, a vaccine candidate for schistosomiasis, and their correlations with resistance and fibrosis in patients infected with Schistosoma japonicum in Leyte, The PhilippinesTakeshi Nara, Kyoichi Iizumi, Hiroshi Ohmae, et al.
American Journal of Epidemiology|June 4, 2025
A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccineStanley Xu, Lina S Sy, Xuan Huang, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigensC E Rudd, E K Barber, K E Burgess, et al.
The Journal of Biological Chemistry|August 8, 2001
Novel differences between two human prion strains revealed by two-dimensional gel electrophoresisT Pan, M Colucci, B S Wong, et al.
Brain Research|March 30, 2001
Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodiesT Liu, T Zwingman, R Li, et al.
Vaccine|April 11, 2025
Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccinesKatia J Bruxvoort, Lina S Sy, Richard Contreras, et al.
Journal of Clinical and Translational Science|August 11, 2022
Evidence-based practice strategies for faculty professional development in clinical translational research at Institutional Development Award (IDeA) state institutions in the Mountain WestMerle R Kataoka-Yahiro, Larissa Myaskovsky, Ruben K Dagda, et al.
Cellular Immunology|February 13, 2001
The expression and potential function of cellular prion protein in human lymphocytesR Li, D Liu, G Zanusso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2015
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal DiseaseHung Fu Tseng, Yi Luo, Jiaxiao Shi, et al.
Pageof 35